{
    "title": "AbbVie sees 37% drop in Humira sales this year as biosimilars hit U.S. market",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11732779/AbbVie-sees-37-drop-Humira-sales-year-biosimilars-hit-U-S-market.html",
    "date": "2023-02-09",
    "keywords": [
        "humira",
        "erosion",
        "competition",
        "end",
        "share",
        "volume",
        "leo",
        "mariam",
        "inc",
        "drug",
        "growth",
        "skyrizi",
        "rinvoq",
        "company",
        "profit",
        "outlook",
        "forecast",
        "decline",
        "market",
        "quarter",
        "thursday",
        "flagship",
        "year",
        "stabilization",
        "newer",
        "autoimmune",
        "floor",
        "street",
        "amgen",
        "summer",
        "truist",
        "analyst",
        "robyn",
        "karnauskas",
        "companys",
        "drop",
        "overhang",
        "stock",
        "fall",
        "price",
        "half",
        "abbvie",
        "vice",
        "chairman",
        "robert",
        "conference",
        "call",
        "question",
        "look",
        "europe",
        "multiple",
        "line",
        "drugmaker",
        "revenue",
        "prescription",
        "beat",
        "e",
        "sunny",
        "bengaluru",
        "wingrove",
        "york",
        "editing",
        "kalluvila",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}